February 21, 2014 13:18 ET
MS Society of Canada and The Centre for Drug Research and Development partner to focus on MS research
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 24, 2014) - This document corrects and replaces the media advisory that was sent on February 21, 2014 at 13:18 PM EST.
The Multiple Sclerosis Society of Canada and The Centre for Drug Research and Development (CDRD) will announce they are accelerating the pace of Canadian research in multiple sclerosis by partnering to transform promising research discoveries into MS therapies to help people affected by the disease.
Barry GeeDirector, CommunicationsThe Centre for Drug Research and Development (CDRD)email@example.comClaudette VillenaMedia Relations & Communications SpecialistMS Society of Canada416-922-6600 firstname.lastname@example.org
See all RSS Newsfeeds
multiple sclerosis MS Society of Canada sclérose en plaques CDRD la recherche en SP